ATE370414T1 - Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs - Google Patents

Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs

Info

Publication number
ATE370414T1
ATE370414T1 AT03813582T AT03813582T ATE370414T1 AT E370414 T1 ATE370414 T1 AT E370414T1 AT 03813582 T AT03813582 T AT 03813582T AT 03813582 T AT03813582 T AT 03813582T AT E370414 T1 ATE370414 T1 AT E370414T1
Authority
AT
Austria
Prior art keywords
colorectal cancer
methyltransferase
nicotinamide
diagnosis
diagnosing colorectal
Prior art date
Application number
AT03813582T
Other languages
English (en)
Inventor
Peter Berndt
Marie-Luise Hagmann
Hanno Langen
Stefan Palme
Markus Roessler
Wolfgang Rollinger
Michael Tacke
Werner Zolg
Johann Karl
Theresa Kott
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE370414T1 publication Critical patent/ATE370414T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03813582T 2002-12-20 2003-12-19 Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs ATE370414T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02028715 2002-12-20

Publications (1)

Publication Number Publication Date
ATE370414T1 true ATE370414T1 (de) 2007-09-15

Family

ID=32668733

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03813582T ATE370414T1 (de) 2002-12-20 2003-12-19 Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs

Country Status (13)

Country Link
US (1) US7205118B2 (de)
EP (1) EP1579220B1 (de)
JP (1) JP4248496B2 (de)
KR (1) KR100711046B1 (de)
CN (1) CN100437115C (de)
AT (1) ATE370414T1 (de)
AU (1) AU2003296684A1 (de)
BR (1) BR0317394A (de)
CA (1) CA2510377C (de)
DE (1) DE60315715T2 (de)
ES (1) ES2291750T3 (de)
MX (1) MXPA05006382A (de)
WO (1) WO2004057336A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05006382A (es) 2002-12-20 2005-10-24 Hoffmann La Roche Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal.
CA2567157A1 (en) * 2004-06-18 2005-12-29 F. Hoffmann-La Roche Ag Use of inorganic pyrophosphatase as a marker for colorectal cancer
WO2006066916A1 (en) * 2004-12-23 2006-06-29 Roche Diagnostics Gmbh Use of microsomal dipeptidase as a marker for colorectal cancer
DE602005014386D1 (de) 2004-12-23 2009-06-18 Roche Diagnostics Gmbh Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
DE602005013430D1 (de) * 2004-12-23 2009-04-30 Roche Diagnostics Gmbh Verwendung von asc als marker für kolorektalkarzinome
KR101314959B1 (ko) 2005-08-19 2013-10-11 인디부메드 게엠베하 결장직장선종 및/또는 결장직장암종에 대한 생체표지로서엔도플라스민 단편 및 그 유도체의 사용； 검출 방법 및시험 시스템
CA2632327A1 (en) * 2005-12-22 2007-06-28 F. Hoffmann-La Roche Ag Use of a marker combination comprising osteopontin and carcinoembryonic antigen in the assessment of colorectal cancer
CA2655851A1 (en) * 2006-08-01 2008-02-07 F. Hoffmann-La Roche Ag Use of nnmt as a marker for lung cancer
WO2008082646A2 (en) * 2006-12-28 2008-07-10 The Johns Hopkins University Histone deacetylase inhibitors, combination therapies and methods of use
KR100883530B1 (ko) 2007-07-30 2009-02-13 한국과학기술연구원 대장암 진단용 단백질 마커 아데노실호모시스테이나제 및이에 대한 항체를 포함하는 대장암 진단키트
KR101458483B1 (ko) 2007-08-06 2014-11-10 제노마인(주) 신장암 진단 조성물 및 키트
CA2747942C (en) 2008-12-22 2016-12-06 F. Hoffmann-La Roche Ag Armet as a marker for cancer
US10815517B2 (en) 2009-04-28 2020-10-27 Roche Diagnostics Operations, Inc. Use of DPPIV/seprase as a marker for cancer
JP5731488B2 (ja) 2009-05-29 2015-06-10 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 癌のマーカーとしてのセセルニン‐１
ES2493070T3 (es) 2009-07-16 2014-09-11 F. Hoffmann-La Roche Ag Flap endonucleasa-1 como marcador para el cáncer
CN102375049A (zh) * 2010-08-04 2012-03-14 索尼公司 生物信息获取方法和烟酰胺代谢物测量方法
WO2012123297A1 (en) * 2011-03-11 2012-09-20 Roche Diagnostics Gmbh Nnmt as marker for chronic obstructive pulmonary disease (copd)
CN106461669A (zh) 2014-05-13 2017-02-22 瓦斯特空公司 外周血及其单核细胞中的甲硫氨酸氨肽酶过表达作为结肠直肠癌筛查、诊断和预后的标记物
CN104894073B (zh) * 2015-02-16 2018-03-27 浙江大学 杂交瘤细胞株Zj/2D8及其检测尼克酰胺‑N‑甲基化酶抗原的应用
CN110308281B (zh) * 2019-06-06 2022-08-23 北京蛋白质组研究中心 一种泛素链固相检测方法和应用
CN116726012B (zh) * 2023-03-16 2026-02-27 华中科技大学同济医学院附属协和医院 Nnmt在炎症性肠病诊断和治疗中的用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547928A (en) 1993-12-17 1996-08-20 Matritech, Inc. Methods and compositions for the detection of colon cancers
WO1996039419A1 (en) 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Colon specific genes and proteins
WO1998020143A1 (en) * 1996-11-05 1998-05-14 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
EP1108021A2 (de) 1998-08-31 2001-06-20 Bayer Corporation Humane gene differentiell exprimiert in kolorektalkrebs
US6936424B1 (en) 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
US20010055596A1 (en) 2000-03-24 2001-12-27 Meagher Madeleine Joy Compositions and methods for therapy and diagnosis of colon cancer
EP1287029A2 (de) 2000-06-09 2003-03-05 Corixa Corporation Zusammensetzungen und verfahren zur therapie und diagnose von dickdarmkrebs
CA2412223A1 (en) 2000-06-09 2001-12-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20020086303A1 (en) 2000-06-09 2002-07-04 Meagher Madeleine Joy Compositions and methods for the therapy and diagnosis of colon cancer
CA2417866A1 (en) 2000-08-03 2002-02-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
AU2001290518A1 (en) 2000-08-03 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
JP2002070501A (ja) 2000-09-04 2002-03-08 Honda Motor Co Ltd 回転流体機械
WO2002078636A2 (en) 2001-03-28 2002-10-10 Matritech, Inc. Detection and treatment of colorectal cancer
WO2002090512A2 (en) * 2001-05-07 2002-11-14 Genaissance Pharmaceuticals, Inc. Haplotypes of the nnmt gene
MXPA05006382A (es) 2002-12-20 2005-10-24 Hoffmann La Roche Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal.

Also Published As

Publication number Publication date
HK1088947A1 (zh) 2006-11-17
WO2004057336A3 (en) 2005-01-20
WO2004057336A2 (en) 2004-07-08
US7205118B2 (en) 2007-04-17
CN1742204A (zh) 2006-03-01
AU2003296684A1 (en) 2004-07-14
DE60315715D1 (de) 2007-09-27
EP1579220A2 (de) 2005-09-28
KR20050114604A (ko) 2005-12-06
US20060003368A1 (en) 2006-01-05
BR0317394A (pt) 2005-11-16
CA2510377C (en) 2009-11-17
JP4248496B2 (ja) 2009-04-02
ES2291750T3 (es) 2008-03-01
EP1579220B1 (de) 2007-08-15
JP2006510889A (ja) 2006-03-30
MXPA05006382A (es) 2005-10-24
CA2510377A1 (en) 2004-07-08
DE60315715T2 (de) 2008-06-05
CN100437115C (zh) 2008-11-26
KR100711046B1 (ko) 2007-04-24

Similar Documents

Publication Publication Date Title
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
NO339224B1 (no) Bedrede immunprøvemetoder
DE60332639D1 (de) Verwendung von biomarkern zum nachweis von eierstockkrebs
ATE554389T1 (de) Apex als marker für lungenkrebs
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
DK1776587T3 (da) Anvendelse af C3a og derivater deraf som biomarkör for colorektalt adenom og/eller carcinom, diagnosemetoder og assays under anvendelse deraf
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
DE602005014386D1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
DE602004005859D1 (de) Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs
WO2004071267A3 (en) Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
ATE522833T1 (de) Vorrichtung zur detektion von chemischen oder biologischen substanzen und verfahren zum reinigen der vorrichtung
ATE418737T1 (de) Verwendung des proteins spermidinsynthase (spee) als marker für kolorektalkarzinom
DE602004017017D1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1579220

Country of ref document: EP